SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Bio-Reference Laboratories, Inc. |
(Name of Issuer) |
Common Stock |
(Title of Class of Securities) |
09057G602 |
(CUSIP Number) |
December 31, 2012 |
(Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
X | Rule 13d-1(b) |
|
|
| Rule 13d-1(c) |
|
|
| Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
PAGE 1 OF 10 PAGES
CUSIP No. 09057G602 |
|
|
1 | NAME OF REPORTING PERSON Manulife Financial Corporation | ||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) o N/A | ||
3 | SEC USE ONLY | ||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Canada | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5 | SOLE VOTING POWER -0- | |
6 | SHARED VOTING POWER -0- | ||
7 | SOLE DISPOSITIVE POWER -0- | ||
8 | SHARED DISPOSITIVE POWER -0- | ||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON None, except through its indirect, wholly-owned subsidiaries, Manulife Asset Management (US) LLC, Manulife Asset Management (North America) Limited and Manulife Asset Management Limited | ||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A | ||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 See line 9 above. | ||
12 | TYPE OF REPORTING PERSON* HC |
*SEE INSTRUCTIONS
PAGE 2 OF 10 PAGES
CUSIP No. 09057G602 |
|
|
1 | NAME OF REPORTING PERSON Manulife Asset Management (US) LLC | ||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) o N/A | ||
3 | SEC USE ONLY | ||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5 | SOLE VOTING POWER 11,752 | |
6 | SHARED VOTING POWER -0- | ||
7 | SOLE DISPOSITIVE POWER 11,752 | ||
8 | SHARED DISPOSITIVE POWER -0- | ||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11,752 | ||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A | ||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.04% | ||
12 | TYPE OF REPORTING PERSON* IA |
*SEE INSTRUCTIONS
PAGE 3 OF 10 PAGES
CUSIP No. 09057G602 |
|
|
1 | NAME OF REPORTING PERSON Manulife Asset Management (North America) Limited | ||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) o N/A | ||
3 | SEC USE ONLY | ||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Canada | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5 | SOLE VOTING POWER 8,899 | |
6 | SHARED VOTING POWER -0- | ||
7 | SOLE DISPOSITIVE POWER 8,899 | ||
8 | SHARED DISPOSITIVE POWER -0- | ||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,899 | ||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A | ||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.03% | ||
12 | TYPE OF REPORTING PERSON* IA |
*SEE INSTRUCTIONS
PAGE 4 OF 10 PAGES
CUSIP No. 09057G602 |
|
|
1 | NAME OF REPORTING PERSON Manulife Asset Management Limited | ||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) o N/A | ||
3 | SEC USE ONLY | ||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Ontario | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5 | SOLE VOTING POWER 2,146,944 | |
6 | SHARED VOTING POWER -0- | ||
7 | SOLE DISPOSITIVE POWER 2,146,944 | ||
8 | SHARED DISPOSITIVE POWER -0- | ||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,146,944 | ||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A | ||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.75% | ||
12 | TYPE OF REPORTING PERSON* FI |
*SEE INSTRUCTIONS
PAGE 5 OF 10 PAGES
CUSIP No. 09057G602 |
|
|
1 | NAME OF REPORTING PERSON Manulife Canadian Focused Fund | ||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) o (b) o N/A | ||
3 | SEC USE ONLY | ||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION Ontario | ||
Number of Shares Beneficially Owned by Each Reporting Person With | 5 | SOLE VOTING POWER -0- | |
6 | SHARED VOTING POWER -0- | ||
7 | SOLE DISPOSITIVE POWER -0- | ||
8 | SHARED DISPOSITIVE POWER -0- | ||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,054,817 shares owned directly by the Fund. Manulife Asset Management Limited has sole voting and dispositive power over these shares. | ||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A | ||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.42% | ||
12 | TYPE OF REPORTING PERSON* FI |
*SEE INSTRUCTIONS
PAGE 6 OF 10 PAGES
Item 1(a)
Name of Issuer:
Bio-Reference Laboratories, Inc.
Item 1(b)
Address of Issuer’s Principal Executive Offices:
481 Edward H. Ross Drive
Elmwood Park, New Jersey 07407
Item 2(a)
Name of Person Filing:
This filing is made on behalf of Manulife Financial Corporation (“MFC”) and MFC’s indirect, wholly-owned subsidiaries, Manulife Asset Management (US) LLC (“MAM (US)”), Manulife Asset Management (North America) Limited (“MAM (NA)”) and Manulife Asset Management Limited (“MAML”), and is also made on behalf of Manulife Canadian Focused Fund.
Item 2(b)
Address of Principal Business Office:
The principal business offices of MFC, MAM (NA), MAML and Manulife Canadian Focused Fund are located at 200 Bloor Street East, Toronto, Ontario, Canada, M4W 1E5.
The principal business office of MAM (US) is located at 101 Huntington Avenue, Boston, Massachusetts 02199.
Item 2(c)
Citizenship:
MFC and MAM (NA) are organized and exist under the laws of Canada.
MAM (US) is organized and exists under the laws of the State of Delaware.
MAML and Manulife Canadian Focused Fund are organized and exist under the laws of Ontario.
Item 2(d)
Title of Class of Securities:
Common Stock
Item 2(e)
CUSIP Number:
09057G602
Item 3
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
MFC:
(g) (X)
a parent holding company or control person in
accordance with §240.13d-1(b)(1)(ii)(G).
MAM (US):
(e) (X)
an investment adviser in accordance with
§240.13d-1(b)(1)(ii)(E).
MAM (NA):
(e) (X)
an investment adviser in accordance with
§240.13d-1(b)(1)(ii)(E).
MAML:
(j) (X)
a non-U.S. institution in accordance with
§240.13d-1(b)(1)(ii)(J).
Manulife Canadian Focused Fund:
(j) (X)
a non-U.S. institution in accordance with
§240.13d-1(b)(1)(ii)(J).
PAGE 7 OF 10 PAGES
Item 4
Ownership:
(a) Amount Beneficially Owned: MAM (US) has beneficial ownership of 11,752 shares of Common Stock, MAM (NA) has beneficial ownership of 8,899 shares of Common Stock and MAML has beneficial ownership of 2,146,944 shares of Common Stock, of which Manulife Canadian Focused Fund owns directly 2,054,817 shares. Through its parent-subsidiary relationship to MAM (US), MAM (NA) and MAML, MFC may be deemed to have beneficial ownership of these same shares.
(b) Percent of Class: Of the 27,709,382 shares outstanding as of January 9, 2013, according to the issuer’s Annual Report filed on Form 10-K for the fiscal year ended October 31, 2012, MAM (US) held 0.04%, MAM (NA) held 0.03% and MAML held 7.75%, of which Manulife Canadian Focused Fund held directly 7.42%.
(c) Number of shares as to which the person has:
(i)
sole power to vote or to direct the vote:
MAM (US), MAM (NA) and MAML each has sole power to vote or to direct the voting of the shares of Common Stock beneficially owned by each of them.
(ii)
shared power to vote or to direct the vote: -0-
(iii)
sole power to dispose or to direct the disposition of:
MAM (US), MAM (NA) and MAML each has sole power to dispose or to direct the disposition of the shares of Common Stock beneficially owned by each of them.
(iv)
shared power to dispose or to direct the disposition of: -0-
Item 5
Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6
Ownership of More than Five Percent on Behalf of Another Person:
Not applicable.
Item 7
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
See Items 3 and 4 above.
Item 8
Identification and Classification of Members of the Group:
Not applicable.
Item 9
Notice of Dissolution of Group:
Not applicable.
Item 10
Certification:
By signing below the undersigned certifies that, to the best of its knowledge and belief, (i) the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, and (ii) the foreign regulatory schemes applicable to MAML and Manulife Canadian Focused Fund, respectively, are substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institutions. The undersigned also undertakes to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.
PAGE 8 OF 10 PAGES
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Manulife Financial Corporation | ||
By: | /s/ Kenneth G. Pogrin | |
Name: | Kenneth G. Pogrin | |
Dated: February 13, 2013 | Title: | Attorney in Fact* |
Manulife Asset Management (US) LLC | ||
By: | /s/ William E. Corson | |
Name: | William E. Corson | |
Dated: February 13, 2013 | Title: | Vice President and Chief Compliance Officer |
Manulife Asset Management (North America) Limited | ||
By: | /s/ Kenneth G. Pogrin | |
Name: | Kenneth G. Pogrin | |
Dated: February 13, 2013 | Title: | General Counsel and Secretary |
Manulife Asset Management Limited | ||
By: | /s/ Kenneth G. Pogrin | |
Name: | Kenneth G. Pogrin | |
Dated: February 13, 2013 | Title: | Vice President, Law |
Manulife Canadian Focused Fund | ||
By: | /s/ Martin Guest | |
Name: | Martin Guest | |
Dated: February 13, 2013 | Title: | VP and Chief Compliance Officer, MAML |
* Signed pursuant to a Power of Attorney dated January 17, 2008 included as an Exhibit to Schedule 13G filed with the Securities and Exchange Commission by Manulife Financial Corporation on January 24, 2008.
PAGE 9 OF 10 PAGES
EXHIBIT A
JOINT FILING AGREEMENT
Manulife Financial Corporation, Manulife Asset Management (US) LLC, Manulife Asset Management (North America) Limited, Manulife Asset Management Limited and Manulife Canadian Focused Fund agree that the Schedule 13G to which this Agreement is attached, relating to the Common Stock of Bio-Reference Laboratories, Inc., is filed on behalf of each of them.
Manulife Financial Corporation | ||
By: | /s/ Kenneth G. Pogrin | |
Name: | Kenneth G. Pogrin | |
Dated: February 13, 2013 | Title: | Attorney in Fact* |
Manulife Asset Management (US) LLC | ||
By: | /s/ William E. Corson | |
Name: | William E. Corson | |
Dated: February 13, 2013 | Title: | Vice President and Chief Compliance Officer |
Manulife Asset Management (North America) Limited | ||
By: | /s/ Kenneth G. Pogrin | |
Name: | Kenneth G. Pogrin | |
Dated: February 13, 2013 | Title: | General Counsel and Secretary |
Manulife Asset Management Limited | ||
By: | /s/ Kenneth G. Pogrin | |
Name: | Kenneth G. Pogrin | |
Dated: February 13, 2013 | Title: | Vice President, Law |
Manulife Canadian Focused Fund | ||
By: | /s/ Martin Guest | |
Name: | Martin Guest | |
Dated: February 13, 2013 | Title: | VP and Chief Compliance Officer, MAML |
* Signed pursuant to a Power of Attorney dated January 17, 2008 included as an Exhibit to Schedule 13G filed with the Securities and Exchange Commission by Manulife Financial Corporation on January 24, 2008.
PAGE 10 OF 10 PAGES